FDA Approves Supplemental Applications for TRELSTAR
The FDA has approved supplemental applications for TRELSTAR, a triptorelin pamoate product.
Asset / Drug
Drug and asset intelligence for Verity with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Hormonal Therapy
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.